[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100546763":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":7,"locations":7,"responsibleParty":13,"collaborators":7,"id":15,"slug":7,"hasResults":16,"nctId":17,"briefTitle":18,"officialTitle":19,"acronym":20,"eligibilityCriteria":21,"healthyVolunteers":16,"sex":22,"minAge":23,"maxAge":7,"enrollmentInfo":24,"targetDuration":27,"studyType":28,"phases":7,"briefSummary":29,"conditions":30,"keywords":7,"overallStatus":32,"whyStopped":7,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":7},{"fullName":5,"class":6},"OncoSil Medical Limited","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DEVICE","OncoSil","Intra-tumoural implantation",{"type":14,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100546763",false,"NCT06399172","OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy","OncoSil Pancreatic Cancer Post-marketing Clinical Registry Italy","OSPRItaly","Inclusion Criteria:\n\n1. Patients who are eligible for and undergo OncoSil™ implantation at an eligible treatment facility according to the approved OncoSil™ System Instructions for Use (IFU), as part of their clinical care.\n2. Patients who have completed and signed the Patient Informed Consent Form (PICF) for the OSPRItaly Patient Registry.\n\nExclusion Criteria:\n\n1. Patients participating in an interventional clinical study (company or investigator-sponsored).\n2. Use of an investigational agent at the time of enrolment.","ALL","18 Years",{"count":25,"type":26},50,"ESTIMATED","1 Year","OBSERVATIONAL","The OSPRItaly Patient Registry has been developed to assess the performance and safety of the OncoSil™ device when used within the approved indication of unresectable, locally advanced pancreatic cancer, in combination with gemcitabine-based chemotherapy, within a real-world observational registry.",[31],"Locally Advanced Pancreatic Adenocarcinoma","NOT_YET_RECRUITING","2024-05-01",{"date":35,"type":36},"2024-05-03","ACTUAL",{"date":38,"type":26},"2024-05-30",{"date":40,"type":26},"2029-10-30",{"name":5,"class":6}]